Inventurus Knowledge Solutions has announced the USD 565 million acquisition of TruBridge Inc., a US-based healthcare IT and revenue cycle management provider. The deal will be executed through a merger with a subsidiary, IKS Next Horizon, Inc. This strategic move aims to diversify the group’s business into the SaaS Electronic Health Records (EHR) segment and enhance its technology-led healthcare service capabilities. The transaction is expected to close within 180 days from April 23, 2026.
Acquisition Overview
Inventurus Knowledge Solutions (IKS) has finalized an agreement to acquire 100% of the shareholding in TruBridge Inc. for a total consideration of up to USD 565 million. The acquisition, approved on April 23, 2026, will be facilitated through the merger of a wholly-owned subsidiary, IKS Next Horizon, Inc., with the target entity under Delaware law.
Strategic Rationale
TruBridge Inc. is a prominent provider of healthcare IT and revenue cycle management services, supporting over 700 community and critical access hospitals in the United States. With a consolidated revenue of USD 346.8 million in 2025, the target company brings a sticky SaaS EHR segment that aligns perfectly with IKS’s mission to become a technology-driven, data-led healthcare services group. The acquisition is expected to significantly expand the group’s consolidated asset base and strengthen its market footprint in the US healthcare sector.
Financing Details
To fund the transaction, IKS Inc. has secured a USD 670 million facilities agreement from a consortium of lenders, including Citibank N.A., Deutsche Bank AG, and JPMorgan Chase Bank. The debt package consists of two term loan facilities of USD 610 million and USD 40 million, along with a USD 20 million revolving credit facility. The financing is supported by a comprehensive security package, which includes corporate guarantees from IKS and its subsidiaries, as well as pledges over shareholdings and corporate assets.
Future Outlook
Following the completion of the merger, TruBridge will operate as a wholly-owned indirect subsidiary of the Company. This integration is designed to enable the combined entity to offer an integrated suite of Electronic Medical Records (EMR) and Care Enablement platform solutions to both existing and new clients. The company expects to finalize the transaction within 180 days, marking a major milestone in its growth strategy.
Source: BSE
